Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-25 @ 2:50 AM
NCT ID:
NCT00863733
Eligibility Criteria:
Inclusion Criteria:
1. Histologically confirmed solid tumor that is not amenable to any standard therapy or is refractory to conventional therapy
2. Performance status WHO 0-2
3. Life expectancy greater than 3 months
4. Hemoglobin at least 90 g/L; WBC at least 3,000/mm3; Platelet count at least 100,000/mm3
5. Bilirubin within normal limits; ALT less than 2 times upper limit of normal (ULN); Alkaline phosphatase less than 2 times ULN
6. Creatinine less than 130 umol/L
7. INR and APTT within normal limits
8. Fertile patients must use effective contraception
9. At least 4 weeks since prior anticancer therapy and recovered from toxic effects
Exclusion Criteria:
1. Concurrent malignancy except cone biopsied carcinoma in situ of the cervix and adequately treated basal or squamous cell carcinoma of the skin
2. Other serious medical condition
3. Uncontrolled infection or serious infection within the past 28 days
4. Pregnant or lactating
5. Treatment with glucocorticosteroids within previous two weeks
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00863733
Study Brief:
Protocol Section:
NCT00863733